Both approaches alter embryonic DNA so the genetic change can become part of the developing animal. CRISPR-Cas9 can be used to introduce, delete, or alter a sequence, whereas transgene insertion adds an experimentally selected sequence. Because the modification occurs in an embryo, researchers can examine its consequences as cells develop and determine whether it is passed to offspring.
Potential inheritance extends the analysis beyond the original pup. When the altered sequence is passed to offspring, researchers can examine whether the genetic change and associated phenotype recur in later generations. This makes it possible to connect a DNA alteration with traits observed at molecular, cellular, or whole-animal levels, while genotyping confirms which animals carry the intended change.
Genotyping verifies whether a pup carries the intended DNA change, rather than assuming that an embryo manipulation succeeded. Appropriate controls provide the comparison needed to judge whether differences in neuronal development, synaptic signaling, behavior, or disease-related phenotypes result from that modification. Together, these safeguards strengthen the link between genotype and observed outcome.
Analysis can connect one genetic change to effects at several biological scales. Molecular measurements may reveal altered gene-related processes, cellular studies can examine neuronal development or synaptic signaling, and whole-animal observations can assess behavior. Using these levels together helps researchers move from a gene-level alteration toward a more complete account of neurological function or disease mechanisms.
Generation begins with modification of an embryo, using CRISPR-Cas9 or transgene insertion to introduce, delete, or alter the sequence of interest. The resulting pups are then evaluated for the intended genetic change through genotyping. Researchers apply appropriate controls before interpreting phenotypes, allowing them to distinguish effects associated with the modification from findings that do not specifically track with it.
These mice are useful when investigators need to connect a particular gene with neuronal development, synaptic signaling, behavior, or neurological disease. A resulting phenotype can point to a disease mechanism and support further study of potential treatments. Because the model permits observation from molecular changes through whole-animal traits, it can integrate evidence that isolated experimental levels cannot provide alone.